Holding(s) in Company

Dechra Pharmaceuticals PLC 21 November 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Dechra Pharmaceuticals PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: ( x ) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) SPECIAL NOTIFICATION REQUIRED BY DTR 3. Full name of person(s) subject to the notification obligation: Schroders plc 4. Full name of shareholder(s) (if different from 3.): 5. Date of the transaction and date on which the threshold is crossed or reached if different): 20/11/07 6. Date on which issuer notified: 21/11/07 7. Threshold(s) that is/are crossed or reached: From 12% - 13% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to if possible using the the Triggering ISIN CODE transaction Number of shares Number of voting Rights Ordinary shares GB0009633180 6,331,425 6,331,425 Resulting situation after the triggering transaction Class/type of shares Number of shares Number of voting rights % of voting rights if possible using the ISIN CODE Direct Indirect Direct Indirect Direct Indirect Ordinary shares GB0009633180 N/A N/A 6,932,568 N/A 13.128% B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Date Exercise/Conversion Number of voting % of voting financial Period/ Date rights that may be rights instrument acquired if the instrument is exercised/ converted. Total (A+B) Number of voting rights % of voting rights 6,932,568 13.128% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: Schroder Investment Management Limited 6,097,449 11.547% Schroder Investment Management North America Limited 835,119 1.581% Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. 14. Contact name: Chris Melrose 15. Contact telephone number: 020 7658 2521 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings